These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10420321)

  • 1. [Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)].
    Steffen T; Uchtenhagen A; Gutzwiller F; Dobler-Mikola A; Blättler R
    Internist (Berl); 1999 Jun; 40(6):651-6. PubMed ID: 10420321
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.
    Güttinger F; Gschwend P; Schulte B; Rehm J; Uchtenhagen A
    Eur Addict Res; 2003 Apr; 9(2):73-9. PubMed ID: 12644733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.
    Dallery J; Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):317-25. PubMed ID: 11534542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing intravenous cocaine use in opiate users treated with prescribed heroin.
    Blättler R; Dobler-Mikola A; Steffen T; Uchtenhagen A
    Soz Praventivmed; 2002; 47(1):24-32. PubMed ID: 12050926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.
    Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
    Eur Addict Res; 2006; 12(2):74-82. PubMed ID: 16543742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with willingness to participate in a heroin prescription program among injection drug users.
    Miller CL; Strathdee SA; Kerr T; Small W; Li K; Wood E
    J Opioid Manag; 2005; 1(4):201-3. PubMed ID: 17315547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
    Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
    Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heroin-assisted treatment of opiate addicts--former and current research emphasis].
    Steffen T; Kaufmann B; Blättler R; Dobler-Mikola A; Gutzwiller F; Uchtenhagen A
    Gesundheitswesen; 1999; 61(8-9):407-12. PubMed ID: 10535222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Matthews AM; Fireman M; Zucker B; Sobel M; Hauser P
    Am J Psychiatry; 2006 Aug; 163(8):1342-7; quiz 1479. PubMed ID: 16877644
    [No Abstract]   [Full Text] [Related]  

  • 14. Heroin for addiction treatment.
    Harv Ment Health Lett; 2002 Dec; 19(6):7. PubMed ID: 12499141
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective cohort study on orally administered heroin substitution for severely addicted opioid users.
    Frick U; Rehm J; Kovacic S; Ammann J; Uchtenhagen A
    Addiction; 2006 Nov; 101(11):1631-9. PubMed ID: 17034443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.
    Smolka M; Schmidt LG
    Addiction; 1999 Aug; 94(8):1191-8. PubMed ID: 10615734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.
    Barajas-Nava L
    J Assoc Nurses AIDS Care; 2017; 28(5):832-833. PubMed ID: 28652132
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder.
    Trafton JA; Minkel J; Humphreys K
    J Stud Alcohol; 2006 Mar; 67(2):228-35. PubMed ID: 16562404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.